Russia resumes Covid vaccine trial after pause
Advertisement
Moscow: Russia has resumed the vaccination of new volunteers in its trial for its flagship Covid-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population.
At the end of October, eight clinics told Reuters that the trial had been temporarily paused for new volunteers, with some clinics citing high demand and a shortage of doses.
Alexander Gintsburg, director of the Gamaleya Institute, which developed and manufactures the vaccine, said at the time that the uptake of new volunteers had only slowed because of a decision to focus on giving those already vaccinated a second dose.
"Vaccination has resumed. Starting on Monday, we are doing the first component (of the two-dose jab) again," a staff member at Moscow Clinic Number 46 told Reuters this week.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.